Monoclonal Antibodies that Bind to Nerve Growth Factor Receptor (NGFR)(ME20.4 and ME82.11)
Inventor(s)
Tech ID
HM131, RA8598
Origin
MAb ME20.4 was prepared by using WM245 melanoma cells as immunogen in BALB/c mice. ME82.11 was derived by immunizing mice with WM 115 melanoma cells. Spleen cells were fused with mouse myeloma P3x63Ag8.653.
Key Words
cell selection, gliomas, human nerve growth factor receptor, immunodiagnostics, melanomas, Monoclonal Antibodies, neuroblastomas
Isotope
IgG1
Applications and Advantages
Identification of NGFR+ cells.
